The word anastomosis is a medical term for a surgical connection between two tubular structures, channels, or passages that typically do not attach. Anastomosis is when surgeons connect two tube-like structures in the body. Anastomosis devices are used during a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect a remaining sections. Thus, there is an increasing demand for anastomosis devices around the world.

Market Dynamics:

Increasing prevalence of cardiovascular and gastrointestinal disease, growing geriatric population, increasing number of surgical procedures, rise in burden of gastrointestinal cancer, and increasing demand for anastomosis devices are some major factors expected to augment growth of the global anastomosis devices market over the forecast period. For instance, in January 2022, Seger Surgical Solutions commenced the development of its next-generation laparoscopic bowel closure device for intracorporeal anastomosis. A new device is capable of aligning, closing, and stapling common opening for intracorporeal anastomosis quickly, securely, and without the need for suturing.

However, factors such as availability of other substitutes and high cost of anastomosis devices are expected to hamper the growth of the global anastomosis devices market.

Key features of the study:

• This report provides in-depth analysis of the global anastomosis devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anastomosis devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Medtronic, Liva Nova PLC, Dextera Surgical Inc. Ethicon US, LLC., Synovis Micro Alliance, Inc., Vitalitec International Inc., and MAQUET Holding B. V. & Co. KG., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anastomosis devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anastomosis devices market.

Detailed Segmentation:

• Global Anastomosis Devices Market, By Product:
  • Disposable
  • Reusable
• Global Anastomosis Devices Market, By Application:
  • Cardiovascular Surgery
  • Gastro-Intestinal Surgery
  • Others
• Global Anastomosis Devices Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Medtronic
  • Liva Nova PLC
  • Dextera Surgical Inc.
  • Ethicon US, LLC.
  • Synovis Micro Alliance, Inc.
  • Vitalitec International Inc.
  • MAQUET Holding B. V. & Co. KG.